SIG — Sigma Healthcare Cashflow Statement
0.000.00%
- AU$32.78bn
- AU$34.67bn
- AU$10.83bn
Annual cashflow statement for Sigma Healthcare, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2023 January 31st | 2024 January 31st | 2025 January 31st | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.597 | 1.69 | 8.04 | 67.6 | 62.5 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 136 | 42 | -316 | 599 | 575 |
| Capital Expenditures | -29.4 | -4.72 | -7.91 | -57.6 | -56.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.795 | 10.5 | 6.31 | 324 | 119 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -28.6 | 5.73 | -1.6 | 266 | 62.6 |
| Financing Cash Flow Items | -0.98 | -0.809 | -1.35 | 0.042 | -2.2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -110 | 296 | -24.7 | -1,001 | -645 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.8 | 344 | -342 | -134 | -7.65 |